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OBJECTIVES: To determine the influence of anxiety on the
progression of disability and examine possible mediators of
the relationship.
DESIGN: Community-based observational study.
SETTING: Women’s Health and Aging Study I, a prospec-
tive observational study with assessments every 6 months
for 3 years.
PARTICIPANTS: One thousand two functionally limited
women aged 65 and older.
MEASUREMENTS: Anxiety symptoms were assessed us-
ing four questions from the Hopkins Symptom Checklist
(nervous or shaky, avoidance of certain things, tense or
keyed up, fearful). Participants who reported experiencing
two or more of these symptoms at baseline were considered
anxious. Anxiety as a predictor of the onset of four types of
disability was examined using Cox proportional hazards
models. Three models were tested: an unadjusted model, a
model adjusted for confounding variables (age, race, vision,
number of diseases, physical performance, depressive symp-
toms), and a mediational model (benzodiazepine and
psychotropic medication use, physical activity, emotional
support).
RESULTS: Nineteen percent of women reported two or
more symptoms of anxiety at baseline. Unadjusted models
indicate that anxiety was associated with a greater risk
of worsening disability: activity of daily living (ADL) dis-
ability (relative risk (RR)5 1.40, 95% confidence interval
(CI)51.10–1.79), mobility disability (RR51.41, 95%
CI5 1.06–1.86), lifting disability (RR5 1.54, 95%
CI5 1.20–1.97), and light housework disability
(RR5 1.77, 95% CI51.32–2.37). After adjusting for con-
founding variables, anxiety continued to predict the devel-
opment of two types of disability: ADL disability
(RR5 1.41, 95% CI51.08–1.84) and light housework
disability (RR51.56, 95% CI5 1.14–2.14). Finally, ben-
zodiazepine and psychotropic medication use, physical ac-
tivity, and emotional support were not significant mediators
of the effect of anxiety on the development of a disability.
CONCLUSION: Anxiety is a significant risk factor for the
progression of disability in older women. Studies are needed
to determine whether treatment of anxiety delays or pre-
vents disability. J Am Geriatr Soc 53:34–39, 2005.
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The effects of anxiety extend beyond that of emotionalfunctioning. Evidence suggests that anxiety is associ-
ated with functional limitations or ‘‘a restriction in or lack
of ability to perform an activity because of impairment.’’1
Previous work on the relationship between anxiety and role
functioning has excluded older adults and has largely fo-
cused on interference with work functioning. A number of
studies in younger samples have demonstrated that anxiety
and work disability (e.g., days of work missed due to anx-
iety) are indeed related.2–6
The potential effect of anxiety on functioning or dif-
ficulty performing activities of daily living (ADLs) and in-
strumental ADLs in older adults has rarely been considered.
Only a few studies have examined these relationships, and
most were cross-sectional, precluding the examination of
anxiety as a precipitating factor. A study of 61 women with
osteoarthritis of the knee indicated that anxiety was signif-
icantly correlated with performance difficulty and activity
limitation, even after statistically controlling for radio-
graphic disease severity.7 More recently, it was demonstrat-
ed that anxiety was correlated with ADL disability in older
adults who had sustained a stroke or broken hip.8 Another
study showed that anxiety was associated with increased
physical disability in a sample of older adults after statis-
tically controlling for a number of variables, including the
number of chronic diseases and functional limitations.9
The work of Dr. Brenes was supported through the Brooks Scholar in
Academic Medicine Award, and by the National Institute of Mental Health
Grant MH65281. The Women’s Health and Aging Study was
supported by Contracts N01-AG-1–2112 and AG-09834 from the National
Institute on Aging.
Address correspondence to Dr. Gretchen A. Brenes, Department of Psychiatry
and Behavioral Medicine, Wake Forest University School of Medicine,
Medical Center Blvd., Winston-Salem, NC 25157.
E-mail: gbrenes@wfubmc.edu
From the Department of Psychiatry and Behavioral Medicine and
zSticht Center on Aging, Wake Forest University, School of Medicine,
Winston-Salem, North Carolina; wEpidemiology, Demography,
and Biometry Program, National Institute on Aging, Bethesda, Maryland;
§Department of Medicine and kDepartment of Epidemiology, Johns
Hopkins Medical Institutions, Baltimore, Maryland; and zClinical
Research Branch, National Institute on Aging, Baltimore, Maryland.
JAGS 53:34–39, 2005
r 2005 by the American Geriatrics Society 0002-8614/05/$15.00
Only two longitudinal studies were identified that ex-
amined anxiety as a predictor of physical disability. One
found that anxiety was a significant predictor of ADL dis-
ability over a 1-year period after controlling for baseline
physical functioning.10 The other followed 198 patients
with coronary artery disease and also found that anxiety
was predictive of functional disability.11 Limitations of
these studies are that participants with disability at baseline
were not excluded from the analyses and that there was a
lack of control for baseline level of physical functioning.
Three variables may explain the relationship between
anxiety and disability: physical activity, benzodiazepine and
psychotropic medication use, and lack of emotional sup-
port. Anxiety may cause people to be less physically active,
thereby causing disability.12,13 Another possibility is that
people with anxiety are more likely to be medicated with
benzodiazepines, which has been linked to a number of
adverse health outcomes in older people, including declines
in functional status, falls, and hip fractures.14,15 Finally,
lack of emotional support, which may promote anxiety, has
been linked to disability in older adults.16
The purpose of this study was to examine the effect of
anxiety on the progression of disability over 3 years in a
large sample of vulnerable older women. The role of phys-
ical activity, benzodiazepine and psychotropic medication
use, and emotional support as mediators of this relationship
were also examined.
METHODS
Study Population
Data are from the Women’s Health and Aging Study I, a 3-
year longitudinal study of the causes and course of disability
in the one-third-most-disabled older women living in the
community.17 An age-stratified random sampling of Medi-
care beneficiaries in Baltimore, Maryland, was undertaken
to identify participants. A total of 5,316 women were el-
igible for screening, and 81% were screened. Of these,
1,409 were eligible for the study, and 1,002 agreed to par-
ticipate. All participants were women aged 65 and older
who had difficulty in at least two of the following domains:
mobility or exercise tolerance (e.g., walking one-quarter of
a mile), upper extremity ability (e.g., raising arms over
head), higher functioning tasks (e.g., using the telephone),
or basic self-care (e.g., bathing). Participants who were
cognitively impaired, as indicated by a Mini-Mental State
Examinaton18 score less than 18, were excluded. All par-
ticipants were interviewed and examined by trained, certi-
fied personnel administering standardized protocols and
questionnaires in their home every 6months over the course
of 3 years. The institutional review board of Johns Hopkins
University School of Medicine and the U.S. Office of Man-
agement and Budget approved this study; all participants
provided written informed consent at enrollment.
Measures
Demographics
Demographic information, including age, race (white, not
white), marital status (married, not married), and years of
education, was obtained.
Anxiety
Anxiety symptoms were assessed using four questions from
the Hopkins Symptom Checklist.19 Participants indicated
whether they felt nervous or shaky, avoided certain things,
felt tense or keyed up, or felt fearful. These four symptoms
were chosen because they are characteristic of most anxiety
disorders. Women who reported that they experienced two
or more of these symptoms of anxiety quite a bit or ex-
tremely frequently over the previous week were considered
to have anxiety. Anxiety symptoms tend to be stable in this
sample. For instance, 54% of participants who reported
anxiety symptoms at baseline also reported anxiety symp-
toms at the 6-month follow-up.
Depression
Depression was assessed using the Geriatric Depression
Scale.20 Responses to the 30 items were summed, and
women who scored 10 or greater were considered to have
high depressive symptoms.
Disability
To capture a full range of severity and effect on function,
disability in four areas was assessed. Participants were
asked to rate their difficulty in performing ADLs (bathing,
dressing, eating, transferring from bed to chair, using the
toilet), walking across a room, lifting 10 pounds, and per-
forming light housework (such as doing dishes, straighten-
ing up, or light cleaning). Responses were ‘‘a little
difficulty,’’ ‘‘some difficulty,’’ ‘‘a lot of difficulty,’’ and ‘‘un-
able to do it.’’ Consistent with previous studies, disability
was considered present if the participant reported ‘‘a lot of
difficulty’’ or inability to perform a task.22,25
Health-Related Characteristics
The presence of 17 major chronic conditions was deter-
mined using standardized algorithms that incorporated
participant self-report of physician diagnosis and of symp-
toms, physical examination findings, medications used,
physician reports, and review of medical records.26 A var-
iable representing the number of validated diseases that
were present was then created. The presence of visual im-
pairment was assessed by asking the women whether they
could see well enough to watch television, read a newspa-
per, or recognize someone across the room. The presence of
a hearing problem was assessed by asking the women
whether they could hear well enough to use the telephone or
to carry on a conversation in a crowded room.
Physical Performance
To adjust for baseline physical function, performance was
assessed using the Short Physical Performance Battery,
which consists of walking 4 m, standing up from and sitting
down in a chair five times, and three sequential standing
balance tests. Participants received a score from 0 (unable
to perform) to 4 (best performance) on each test, based on
scoring criteria from the Established Populations for
Epidemiologic Studies of the Elderly.27 Scores on each test
were summed to create a summary measure of physical
performance that ranged from 0 to 12, with higher scores
indicating better performance.
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Possible Mediators
Three mediating variables that could potentially help ex-
plain the link between anxiety and disability were exam-
ined: benzodiazepine and psychotropic medication use,
physical activity, and emotional support. During the inter-
views, participants displayed all the medications (prescrip-
tion and over the counter) they had used within the previous
2 weeks, and all medications used by participants were re-
corded. Interviewers transcribed the names and dosages of
all medications. This method of medication ascertainment
is similar to that used in other large epidemiological studies
and has been shown to be reliable and valid.28 For this
report, a dichotomous variable (yes/no) represented the use
of benzodiazepines and psychotropic medications. Physical
activity was assessed by asking participants how many
blocks they hadwalked during the previous week. Amedian
split was performed; responses are represented by a dichot-
omous variable (o5 blocks/5 blocks). Emotional support
was assessed by asking participants whether they could
have used more emotional support than they received in the
previous year (yes/no).
Statistical Analyses
A two-step process was used to examine the relationship
between anxiety and the progression of disability. To de-
termine characteristics associated with baseline anxiety,
bivariate relationships between anxiety and baseline demo-
graphics, health-related characteristics, and physical func-
tioning were tested using t tests or chi-square (w2) analyses.
Variables that were significantly related to baseline anxiety
were entered as covariates in regression analyses. In the
second step, a series of proportional hazards models using
Cox regression analyses were conducted. Dependent vari-
ables included the time to onset of disability in each of the
four areas: ADLs, mobility, lifting, and light housework.
Only participants who reported no disability at baseline in a
particular area were included in the analyses, and the first
report of disability was considered the event of incident
disability, regardless of the participant’s status at subse-
quent interviews. Individuals who died or were lost to fol-
low-up were censored after their last interview. Participants
who survived with no evidence of progression of disability
were censored at 3 years. Model 1 presents baseline anxiety
as a predictor of worsening disability. InModel 2, age, race,
vision problems, number of diseases, objective physical
performance, and depression were entered as covariates. In
Model 3, benzodiazepine and psychotropic medication use,
physical activity, and emotional support were added to the
regression analyses to determine whether they were medi-
ators of the effects of anxiety on disability.
RESULTS
The Women’s Health and Aging Study (WHAS) sample
consisted of 1,002 disabled older women with an average
age  standard deviation of 78.3  8.1. All women had at
least two disabilities at baseline; 33.0% had an ADL dis-
ability, 16.0% had a mobility disability, 35.1% had a lifting
disability, and 17.1% had a light housework disability.
Nineteen percent of the sample reported two or more
symptoms of anxiety at baseline. As shown in Table 1,
anxiety symptoms were associated with race, vision,
number of diseases, baseline physical performance, and de-
pressive symptoms. White race (P5.04), vision problems
(P5.03), greater comorbidity (P5.01), poorer physical
performance (Po.001), and depressive symptoms
(Po.001) were associated with anxiety. Bivariate relation-
ships between anxiety and the mediator variables (ben-
zodiazepine and psychotropic medication use, physical
activity, and emotional support) were also examined. Anx-
iety was associated with greater benzodiazepine use
(Po.001), greater psychotropic medication use (Po.001),
and insufficient emotional support (Po.001). These vari-
ables were entered into a logistic regression analysis to de-
termine their relationship with anxiety, independent of each
variable. Number of comorbid conditions (odds ratio
(OR)51.15, 95% confidence interval (CI)51.01–1.30),
depressive symptoms (OR54.79, 95% CI53.32–6.91),
benzodiazepine use (OR5 1.98, 95%CI51.15–3.40), and
emotional support (OR50.43, 95% CI5 0.30–0.62) had
significant relationships with anxiety independent of the
other variables.
The percentage of women developing another func-
tional difficulty over the course of the study was 63.5% for
any ADL, 34.3% for mobility, 64.9% for lifting, and
29.6% for light housework. For each area of difficulty,
women who expressed anxiety symptoms were more likely
to report another functional difficulty in subsequent follow-
ups (Figure 1).
Significant covariates in the model predicting ADL
disability were age (relative risk (RR)51.02, 95% CI5
1.00–1.03) and physical performance (RR50.87, 95%
CI50.84–0.90). Significant covariates in the model predict-
ing mobility disability were age (RR51.02, 95%CI51.00–
1.03), physical performance (RR50.76, 95% CI50.72–
0.80), and comorbidities (RR51.09, 95% CI51.00–1.19).
Significant covariates in the model predicting lifting disability
were physical performance (RR50.89, 95% CI50.86–
0.93), comorbidities (RR5 1.16, 95% CI51.08–1.24), and
depressive symptoms (RR51.26, 95%CI51.01–1.58). Sig-
nificant covariates in the model predicting light housework
disability were age (RR51.02, 95% CI51.00–1.04), vision
(RR50.68, 95% CI50.49–0.93), and physical perform-
ance (RR50.82, 95% CI50.78–0.87).
Table 2 presents the results of the Cox proportional
hazards models. Model 1 consists of the unadjusted RRs of
developing another functional difficulty. Anxiety was asso-
ciated with a greater risk of developing difficulty with
ADLs, mobility, lifting, and light housework. After adjust-
ing for baseline differences in age, race, vision, number of
diseases, physical performance, and depressive symptoms
(Model 2), anxiety remained a significant predictor of de-
veloping difficulty with ADLs and light housework. The
relationships between mobility difficulty and lifting diffi-
culty were no longer significant.
Three possible mediators of the effects of anxiety on the
development of disability were considered: benzodiazepine
and psychotropic medication use, physical activity, and ad-
equate emotional support. Because there was no significant
relationship between anxiety and physical activity (Table
1), physical activity was not considered in further models.
Benzodiazepine and psychotropic medication use were en-
tered into one analysis, and emotional support was entered
into another regression analysis in the step containing
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anxiety. A variable was considered to be a mediator if it
accounted for a significant proportion of the variance in
disability and if it reduced the RR of anxiety by 10% or
more. None of the variables met these criteria. Emotional
support was not related to new onset of difficulty in any of
the four areas, and the addition of benzodiazepine and psy-
chotropic medication use was related only to new difficulty
in lifting. Only benzodiazepine use was significant in this
model (w2 (3)512.12, P5.007), although it had no effect
on the relationship between anxiety and disability. Thus,
none of the proposed variables were significant mediators
of the effect of anxiety on the progression of disability.
DISCUSSION
Anxiety symptoms are common in older adults. The results
of this study indicate that 19% of the older women in the
sample experienced symptoms of anxiety, consistent with
findings from community surveys.29,30 Previous research
indicates that anxiety is associated with disability,1,9,10,31
but these studies have largely employed cross-sectional de-
signs, which limit the ability to examine anxiety as a risk
factor for functional decline. This study provides evidence
that anxiety is associated with the progression of disability
in vulnerable older women, independent of several poten-
tial confounding factors.
A key confounding factor is the presence of depressive
symptoms that are often present with anxiety.32,33 Depres-
sion has been identified as a risk factor for physical disa-
bility (see34 for a review), yet the role of anxiety in the
development of disability independent of depressive symp-
toms has not been studied. In this study, the role of anxiety
as a predictor of worsening disability was examined while
controlling for depression. It was found that depression was
significantly related only to lifting disability. Depressive
symptoms were not related to the three other types of dis-
ability. Anxiety, alternatively, remained a significant pre-
dictor of ADL and light housework disabilities. Thus, these
results establish anxiety as a risk factor for the progression
of disability independent of depressive symptoms.
In an effort to begin to understand the effect of anxiety
on disability, three possible mediators were examined:
physical activity, benzodiazepine and psychotropic medi-
cation use, and lack of emotional support. The results of
this study failed to provide support for the idea that these
three variables play a mediating role in the relationship be-
tween anxiety and disability. How then can the link
between anxiety and the progression of disability be
explained? Anxiety may be reflective of preterminal
Table 1. Sociodemographic and Health-Related Characteristics Associated with Anxiety: Women’s Health and Aging Study
I (N51,002)
Variable
No Anxiety
(n5 812)
Anxiety
(n5 190) P-value
Age, mean  SD 78.  38.0 78.4  8.4 .94
African American, % 30.3 22.6 .04
Married, % 20.8 22.1 .70
Education, years, mean  SD 9.9  4.7 9.9  6.9 .94
Vision problem, % 15.6 22.1 .03
Hearing problem, % 20.1 24.7 .16
Number of diseases, mean  SD 2.0  1.4 2.5  1.4 .01
Body mass index, mean  SD 28.5  6.8 27.8  6.8 .23
Summary performance score, mean  SD 6.1  3.2 5.4  3.4 o.001
Depressive symptoms, % 23.6 66.3 o.001
Benzodiazepine use, mean  SD 7.1 15.8 o.001
Physically active, % 14.9 11.9 .19
Had enough emotional support in prior year, % 74.9 47.4 o.001
Number of domains of disability, mean  SD 2.98  0.86 3.36  0.78 o.001
Psychotropic medication use, % 16.5 27.9 o.001
Note: Psychotropic medications include barbiturates, monamine oxidase inhibitors, selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake
inhibitors, trazodone, and tricyclics, and were used on a routine or as-needed basis.
Defined as a score of 10 on the Geriatric Depression Scale.
SD5 standard deviation.
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Figure 1. Anxiety and the progression of disability. ADLs5 ac-
tivities of daily living.
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psychiatric phenomena that lead to disability, but in this
sample, anxiety was not found to be related to 3-year mor-
tality (P4.52; data not shown). Somatic symptoms of anx-
iety may affect functional capacity. For example, feeling
dizzy or shaky could make it difficult to walk across the
room and perform daily activities. Another possibility is
that anxiety may precede physical diseases that cause dis-
ability. Anxiety is a risk factor for hypertension35,36 and
heart disease,37 both of which could result in increased dis-
ability. Anxiety may have an effect on immune dysregula-
tion, such as by slowing down immune responses to
pathogens and thereby increasing one’s susceptibility to
disease.38 Nevertheless, anxiety could also lead to curtailing
activity levels because of perception of risk. Finally, anxiety
itself could be a confounder for other factors associated
with disability but not explored here, such as impaired bal-
ance or falling. Further studies are needed to examine these
and other possible mediators.
The main limitation of this paper is that the sample
consists of disabled women. All participants had difficulty
in at least two domains of functioning at the start of the
study, but because difficulty was assessed in a number of
areas and the sample was large, it was possible to examine
the progression of disability in older women, which is a
strength of this study. Another limitation of this study is
that anxiety symptoms, rather than anxiety disorders, are
assessed. A clinical interview that assesses specific anxiety
disorders would be ideal. Nonetheless, the items were cho-
sen from the well-validated Hopkins Sympton Checklist
because they are key symptoms of anxiety that are charac-
teristic of most anxiety disorders. It is impressive that it was
possible to identify a group at risk for the worsening of
disability using only four questions. Another strength of this
study was that it was possible to examine measures of dis-
ability in multiple areas that are ecologically valid for older
adults. Finally, this study examined the role of anxiety as
a risk for disabilitywhile controlling for depressive symptoms.
Anxiety is a common yet understudied problem for
many older adults. This study found that anxiety is prev-
alent and is independently associated with the progression
of disability in older adults, even after statistically control-
ling for confounding variables. Women with anxiety symp-
toms were 28% to 67% more likely to demonstrate greater
functional difficulty than women without anxiety. This
suggests that anxiety needs to be given more attention. The
results need to be followed with trials that test the effect of
the treatment of anxiety on the delay or even prevention of
disability.
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